Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Jerome Charles Bressi Insider Profile
4 Followers
Jerome Charles Bressi, Chief Regulatory and Quality Officer at Fate Therapeutics, holds 335.20K shares in Fate Therapeutics (Ticker: FATE).
Jerome Charles Bressi has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Jerome Charles Bressi's holdings
Insider Roles
Chief Regulatory and Quality Officer
Roles that Jerome Charles Bressi holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Jerome Charles Bressi
Jerome Charles Bressi's Trading History
List of latest transactions for each holding click on a transaction to see Jerome Charles Bressi's performance on stock
You May Also Like
Jerome Charles Bressi insider profile FAQ
What is the percentage of profitable transactions made by Jerome Charles Bressi?
The percentage of profitable transactions made by Jerome Charles Bressi is ―.
What is the average return per transaction made by Jerome Charles Bressi?
The average return per transaction made by Jerome Charles Bressi is ―.
What stocks does Jerome Charles Bressi hold?
Jerome Charles Bressi holds: FATE stocks.
What was Jerome Charles Bressi’s latest transaction?
Jerome Charles Bressi latest transaction was an Uninformative Buy of ―.
What was Jerome Charles Bressi's most profitable transaction?
Jerome Charles Bressi’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Jerome Charles Bressi's role in Fate Therapeutics?
Jerome Charles Bressi's role in Fate Therapeutics is Chief Regulatory and Quality Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.